1. Home
  2. HALO vs ALSN Comparison

HALO vs ALSN Comparison

Compare HALO & ALSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • ALSN
  • Stock Information
  • Founded
  • HALO 1998
  • ALSN 1915
  • Country
  • HALO United States
  • ALSN United States
  • Employees
  • HALO N/A
  • ALSN N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • ALSN Auto Parts:O.E.M.
  • Sector
  • HALO Health Care
  • ALSN Consumer Discretionary
  • Exchange
  • HALO Nasdaq
  • ALSN Nasdaq
  • Market Cap
  • HALO 7.4B
  • ALSN 7.6B
  • IPO Year
  • HALO N/A
  • ALSN 2012
  • Fundamental
  • Price
  • HALO $49.64
  • ALSN $105.10
  • Analyst Decision
  • HALO Buy
  • ALSN Hold
  • Analyst Count
  • HALO 9
  • ALSN 8
  • Target Price
  • HALO $63.56
  • ALSN $98.63
  • AVG Volume (30 Days)
  • HALO 3.0M
  • ALSN 707.4K
  • Earning Date
  • HALO 05-06-2025
  • ALSN 05-01-2025
  • Dividend Yield
  • HALO N/A
  • ALSN 1.02%
  • EPS Growth
  • HALO 55.40
  • ALSN 16.00
  • EPS
  • HALO 3.76
  • ALSN 8.64
  • Revenue
  • HALO $1,084,306,000.00
  • ALSN $3,202,000,000.00
  • Revenue This Year
  • HALO $24.79
  • ALSN $1.02
  • Revenue Next Year
  • HALO $22.65
  • ALSN $3.87
  • P/E Ratio
  • HALO $13.03
  • ALSN $12.20
  • Revenue Growth
  • HALO 25.64
  • ALSN 3.86
  • 52 Week Low
  • HALO $41.28
  • ALSN $71.49
  • 52 Week High
  • HALO $70.51
  • ALSN $122.53
  • Technical
  • Relative Strength Index (RSI)
  • HALO 34.26
  • ALSN 71.36
  • Support Level
  • HALO $47.50
  • ALSN $104.48
  • Resistance Level
  • HALO $69.94
  • ALSN $105.68
  • Average True Range (ATR)
  • HALO 3.34
  • ALSN 2.00
  • MACD
  • HALO -1.51
  • ALSN 1.29
  • Stochastic Oscillator
  • HALO 6.30
  • ALSN 96.21

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About ALSN Allison Transmission Holdings Inc.

Allison Transmission is the largest manufacturer of fully automatic transmissions for commercial vehicles. The company's automatic transmissions allow customers to achieve better fuel and operator efficiency than less expensive manual and automated manual transmissions. Allison serves several end markets, including on- and off-highway equipment and military vehicles. Its on-highway business has about 60% global market share. The company's transmissions can be found in Class 4-8 trucks, buses, and a limited number of large passenger vehicles (heavy-duty pickup trucks and motor homes). Allison also produces electric hybrid propulsion systems and is developing e-powertrains.

Share on Social Networks: